Avanos Medical AVNS

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.01 (+0.07%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Avanos Medical (AVNS)
    Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $15.24

    • Market Cap

      $701.09 Million

    • Price-Earnings Ratio

      -1.79

    • Total Outstanding Shares

      46 Million Shares

    • Total Employees

      2,227

    • Dividend

      No dividend

    • IPO Date

      October 21, 2014

    • SIC Description

      Orthopedic, Prosthetic & Surgical Appliances & Supplies

    • Primary Exchange

      New York Stock Exchange

    • Type

      Common Stock

    • Headquarters

      5405 windward parkway, Alpharetta, GA, 30004

    • Homepage

      https://www.avanos.com

    Historical Stock Splits

    If you bought 100 shares of AVNS before May 15, 2006, you'd have 1 share today.
    Execution DateSplit Amount
    May 15, 20061-for-100 (Reverse Split)

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Investing Activities, Continuing$-27.50 Million
    Net Cash Flow, Continuing$24.10 Million
    Net Cash Flow From Financing Activities, Continuing$-49.10 Million
    Net Cash Flow From Operating Activities, Continuing$100.70 Million
    Net Cash Flow$20 Million
    Net Cash Flow From Investing Activities$-27.50 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Income Tax Expense/Benefit, Deferred$-35.90 Million
    Diluted Earnings Per Share$-8.53
    Revenues$687.80 Million
    Net Income/Loss Attributable To Noncontrolling Interest$0
    Gross Profit$381.30 Million
    Preferred Stock Dividends And Other Adjustments$0

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss$-409.70 Million
    Other Comprehensive Income/Loss Attributable To Parent$-17.60 Million
    Comprehensive Income/Loss Attributable To Parent$-409.70 Million
    Other Comprehensive Income/Loss$-409.70 Million

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Inventory$138.80 Million
    Other Non-current Assets$537.80 Million
    Equity Attributable To Parent$828.50 Million
    Noncurrent Liabilities$159.80 Million
    Equity$828.50 Million
    Other Non-current Liabilities$34.50 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AVNS from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.